Is it appropriate to study blood ghrelin and obestatin in non-alcoholic fatty liver disease (NAFLD) without using protease inhibitors?

Basit Öğe Kaydı
dc.contributor.authorAydin, Suleyman
dc.date.accessioned2026-08-12T17:46:26Z
dc.date.issued2012
dc.departmentFırat Üniversitesi
dc.description.abstract[Abstract Not Available]
dc.identifier.doi10.1016/S1665-2681(19)31501-7
dc.identifier.endpage146
dc.identifier.issn1665-2681
dc.identifier.issue1
dc.identifier.pmid22166576
dc.identifier.scopus2-s2.0-83055197018
dc.identifier.scopusqualityQ1
dc.identifier.startpage145
dc.identifier.urihttps://doi.org/10.1016/S1665-2681(19)31501-7
dc.identifier.urihttps://hdl.handle.net/11508/61073
dc.identifier.volume11
dc.identifier.wosWOS:000300213500021
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier Espana
dc.relation.ispartofAnnals of Hepatology
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260511
dc.titleIs it appropriate to study blood ghrelin and obestatin in non-alcoholic fatty liver disease (NAFLD) without using protease inhibitors?
dc.typeLetter

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu